https://www.selleckchem.com/pr....oducts/oxiglutatione
Only the BTS and Lung-RADS were on the efficient frontier, with an incremental cost-effectiveness ratio (ICER) of $52 634 (95% CI $45 122, $60 619). Under nearly all sensitivity analyses, the only algorithms on the efficient frontier were BTS and Lung-RADS. The ICERs for BTS versus Lung-RADS were under $100 000 for all scenarios except an increased life expectancy in patients without cancer, in which case the ICER was $109 273. The BTS algorithm and Lung-RADS were cost-effective for managing category 4 nodules, with BTS yielding g
Like
Comment
Share
